| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Illustrating the extent of the boom, Quest Diagnostics on Thursday raised its full-year revenue outlook by hundreds of millions of dollars. The Secaucus, N.J.–based company cited "stronger than anticipated" demand for its molecular Covid tests since it released its second quarter financial results and full-year guidance on July 22.
A new study suggests that U.S. cancer diagnoses have declined because of pandemic-related upheaval. Researchers from Quest Diagnostics used records of newly diagnosed cancer patients who received testing at Quest. In the year before the pandemic hit, the monthly average of new diagnoses was 32,000. In the most recent period, November 2020 to March 2021, the monthly average was about 26,000 — suggesting thousands of people skipped screening tests or checkups in the last year.
New cancer diagnoses in the U.S. remained below the pre-pandemic period over the winter despite evidence cases were missed earlier in 2020, according to an analysis of data from Quest Diagnostics.
Quest Diagnostics, the nation’s leading provider of diagnostic information services, announced it has acquired select assets of Nationwide Laboratory Services (NLS), an independent clinical diagnostics laboratory headquartered in Boca Raton, FL with over 25 years of patient-centric service throughout the country.
The average positive rate for SARS-CoV-2, including the Delta variant, has steadily increased over the past six weeks, says a spokesperson at Quest Diagnostics. This is what fully vaccinated and unvaccinated people need to know about the dominant Delta variant.